DANA WILLIAMS: Open Payments
NPI 1760071492 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$575 in 20 payments from 8 companies in 2025. Trend: 2023 $1,958 · 2024 $502 · 2025 $575
Food & beverage: $521Consulting: $54
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $265 |
| Novartis Pharmaceuticals Corporation | 1 | $86 |
| ADMA BioManufacturing LLC | 4 | $54 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| PFIZER INC. | 2 | $43 |
| BioCryst US Sales Co., LLC | 1 | $34 |
| CSL Behring | 1 | $22 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
Products named: DUPIXENT, OCTAGAM IMMUNE GLOBULIN (HUMAN), NUCALA, ORLADEYO, Hizentra, NEFFY, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
